By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina this week said that Macrogen, a Korea-based sequencing services firm, has purchased an additional 10 HiSeq 2000 systems and two MiSeq systems, in addition to upgrades for its HiSeq 2500. Macrogen also intends to develop diagnostic tests based on the MiSeq platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.